127 related articles for article (PubMed ID: 36281138)
1. Long-term effects of hematopoietic growth factors in aplastic anemia patients treated with immunosuppression: Meta-analysis of randomized controlled trials.
Wang A; Su D; Luo J; Fu Y; Li Q; Chen S
Medicine (Baltimore); 2022 Oct; 101(42):e31103. PubMed ID: 36281138
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis.
Gurion R; Gafter-Gvili A; Paul M; Vidal L; Ben-Bassat I; Yeshurun M; Shpilberg O; Raanani P
Haematologica; 2009 May; 94(5):712-9. PubMed ID: 19336743
[TBL] [Abstract][Full Text] [Related]
3. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
Geng C; Liu X; Chen M; Yang C; Han B
Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis.
Zhang Y; Li J; Li X; Geng Q; Xie Y; Zhang G; Wei M; Ma Y
Syst Rev; 2024 Apr; 13(1):101. PubMed ID: 38576005
[TBL] [Abstract][Full Text] [Related]
5. The Risk of Clonal Evolution of Granulocyte Colony-Stimulating Factor for Acquired Aplastic Anemia: A Systematic Review and Meta-Analysis.
Ding SX; Chen T; Wang T; Liu CY; Lu WL; Fu R
Acta Haematol; 2018; 140(3):141-145. PubMed ID: 30253387
[TBL] [Abstract][Full Text] [Related]
6. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria.
Martí-Carvajal AJ; Anand V; Cardona AF; Solà I
Cochrane Database Syst Rev; 2014 Oct; (10):CD010340. PubMed ID: 25356860
[TBL] [Abstract][Full Text] [Related]
7. Management of aplastic anemia after failure of frontline immunosuppression.
Pierri F; Dufour C
Expert Rev Hematol; 2019 Oct; 12(10):809-819. PubMed ID: 31311355
[No Abstract] [Full Text] [Related]
8. The predictive value of pre-treatment paroxysmal nocturnal hemoglobinuria clone on response to immunosuppressive therapy in patients with aplastic anemia: a meta-analysis.
Wang B; He B; Zhu YD; Wu W
Hematology; 2020 Dec; 25(1):464-472. PubMed ID: 33269994
[TBL] [Abstract][Full Text] [Related]
9. Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA-Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
Alotaibi H; Aljurf M; de Latour R; Alfayez M; Bacigalupo A; Fakih RE; Schrezenmeier H; Ahmed SO; Gluckman E; Iqbal S; Höchsmann B; Halkes C; de la Fuente J; Alshehry N; Cesaro S; Passweg J; Dufour C; Risitano AM; DiPersio J; Motabi I
Transplant Cell Ther; 2022 Feb; 28(2):105.e1-105.e7. PubMed ID: 34649020
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty.
Abudou M; Wu T; Evans JR; Chen X
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007603. PubMed ID: 26313245
[TBL] [Abstract][Full Text] [Related]
11. Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation.
Drexler B; Zurbriggen F; Diesch T; Viollier R; Halter JP; Heim D; Holbro A; Infanti L; Buser A; Gerull S; Medinger M; Tichelli A; Passweg JR
Ann Hematol; 2020 Nov; 99(11):2529-2538. PubMed ID: 32948913
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of eltrombopag in patients with aplastic anemia: a systematic review and meta-analysis of randomized controlled trials.
Guo H; Liu C; Kang L; Liu C; Liu Y
Hematology; 2024 Dec; 29(1):2335419. PubMed ID: 38553907
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.
Fairfield C; Penninga L; Powell J; Harrison EM; Wigmore SJ
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD007606. PubMed ID: 29630730
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
15. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
[TBL] [Abstract][Full Text] [Related]
16. Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.
Kamio T; Ito E; Ohara A; Kosaka Y; Tsuchida M; Yagasaki H; Mugishima H; Yabe H; Morimoto A; Ohga S; Muramatsu H; Hama A; Kaneko T; Nagasawa M; Kikuta A; Osugi Y; Bessho F; Nakahata T; Tsukimoto I; Kojima S;
Haematologica; 2011 Jun; 96(6):814-9. PubMed ID: 21422115
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation.
Tichelli A; de Latour RP; Passweg J; Knol-Bout C; Socié G; Marsh J; Schrezenmeier H; Höchsmann B; Bacigalupo A; Samarasinghe S; Rovó A; Kulasekararaj A; Röth A; Eikema DJ; Bosman P; Bader P; Risitano A; Dufour C;
Haematologica; 2020 May; 105(5):1223-1231. PubMed ID: 31582549
[TBL] [Abstract][Full Text] [Related]
18. Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.
Groarke EM; Patel BA; Shalhoub R; Gutierrez-Rodrigues F; Desai P; Leuva H; Zaimoku Y; Paton C; Spitofsky N; Lotter J; Rios O; Childs RW; Young DJ; Dulau-Florea A; Dunbar CE; Calvo KR; Wu CO; Young NS
Leukemia; 2022 Sep; 36(9):2328-2337. PubMed ID: 35896822
[TBL] [Abstract][Full Text] [Related]
19. Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis.
Zhu Y; Gao Q; Hu J; Liu X; Guan D; Zhang F
BMC Immunol; 2020 Mar; 21(1):10. PubMed ID: 32138642
[TBL] [Abstract][Full Text] [Related]
20. Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation?
Huang LF; Li L; Jia JS; Yang Y; Lin SY; Meng FK; Zhang DH; He GS
Transplant Cell Ther; 2022 Sep; 28(9):586.e1-586.e7. PubMed ID: 35609866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
